These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 11031850)

  • 1. [Evaluation of the vaccination campaign in Cantabria 2 years of epidemiological evolution].
    González de Aledo A; García Merino J
    Rev Esp Salud Publica; 2000; 74(4):405-11. PubMed ID: 11031850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evolution of meningococcal infection among infant population in the autonomous community of Valencia (1996-2000). Effectiveness of A+C meningococcal vaccination].
    Goicoechea Sáez M; Fullana Montoro AM; Momparler Carrasco P; Redondo Gallego MJ; Brines Solanes J; Bueno Cañigral FJ
    Rev Esp Salud Publica; 2003; 77(1):125-42. PubMed ID: 12696392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evolution of meningococcal disease in the community of Madrid. Effectiveness of antimeningococcal A+C vaccination].
    Gutiérrez Rodríguez MA; Ramírez Fernández R; García Gutiérrez J; Moreno Civantos A; Hernando García M; Arce Arnáez A; Sendra Gutiérrez JM; Bueno Vallejos R
    Rev Esp Salud Publica; 2000; 74(4):397-403. PubMed ID: 11031849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Seroprevalence of bactericidal anti-meningococcal antibodies in Cantabria 10 months following a vaccination campaign].
    González de Aledo Linos A; García Merino J
    Rev Esp Salud Publica; 1998; 72(4):365-74. PubMed ID: 9810841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of 2 vaccination strategies on developments during the epidemic of meningococcal A meningitis in N'Djamena (Chad) in 1988].
    Spiegel A; Greindl Y; Lippeveld T; Decam C; Granga D; Nahor N; Bordonado JL; Sperber G; Yankalbe M; Baudon D
    Bull World Health Organ; 1993; 71(3-4):311-5. PubMed ID: 8324849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of an immunization campaign with group A and C meningococcal polysaccharide vaccine in controlling an outbreak of group C meningococcal disease].
    Gong J; Li CY; Dong BQ; Huang JZ; Quan Y; Lu WZ; Luo CH; Mao WC; Liao HZ; Fang JS; Cui XL; Xie GL; Wu XH; Lan RW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):552-5. PubMed ID: 19040035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.
    Cardeñosa N; Domínguez A; Martínez A; Alvarez J; Pañella H; Godoy P; Minguell S; Camps N; Vázquez JA;
    Infection; 2003 Dec; 31(6):392-7. PubMed ID: 14735381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Meningococcal disease. The situation in Spain in the 1998-1999 period].
    Cano Portero R; García Delgado C; de Mateo Ontañón S
    Rev Esp Salud Publica; 2000; 74(4):369-75. PubMed ID: 11031845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York.
    Weiss D; Stern EJ; Zimmerman C; Bregman B; Yeung A; Das D; Dentinger CM; Marx MA; Kornblum J; Lee L; Halse TA; Mayer LW; Hatcher CP; Theodore MJ; Schmink S; Harcourt BH; Zucker JR; Layton M; Clark TA;
    Clin Infect Dis; 2009 Apr; 48(7):894-901. PubMed ID: 19231975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of previous immunisation on the incidence of meningococcal disease during an outbreak in a Sahelian area of Senegal.
    Chippaux JP; Diallo A; Marra A; Etard JF
    Vaccine; 2007 Feb; 25(10):1712-8. PubMed ID: 17240492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recommendation of vaccination against meningitis C in Cantabria].
    González de Aledo Linos A
    An Esp Pediatr; 2001 Oct; 55(4):379-80. PubMed ID: 11578550
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of the meningococcal C conjugate vaccine in Spain: an epidemiological and microbiological decision.
    Cano R; Larrauri A; Mateo S; Alcalá B; Salcedo C; Vázquez JA
    Euro Surveill; 2004 Jul; 9(7):11-5. PubMed ID: 15318008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Control of an epidemic of meningococcal meningitis in Central Africa].
    Merlin M; Martet G; Debonne JM; Nicolas P; Bailly C; Yazipo D; Bougère J; Todesco A; Laroche R
    Sante; 1996; 6(2):87-95. PubMed ID: 8705135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meningococcal disease in the Netherlands: media hype, but not an epidemic].
    van Furth AM; Zaaijer HL
    Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1716-8. PubMed ID: 11572168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal C vaccines: the Canadian experience.
    De Wals P
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S280-4. PubMed ID: 15597070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Meningococcal disease in the City of Havana before and after vaccination].
    Rodríguez AP; Serpa IM; García M
    Rev Cubana Med Trop; 2002; 54(2):106-12. PubMed ID: 15849936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in epidemiological pattern of Meningococcal disease in Saudi Arabia. Does it constitute a new challenge for prevention and control?
    Al-Mazrou YY; Al-Jeffri MH; Abdalla MN; Elgizouli SA; Mishskas AA
    Saudi Med J; 2004 Oct; 25(10):1410-3. PubMed ID: 15494812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The antimeningococcal vaccination campaign in Cantabria, February-March 1997].
    González de Aledo Linos A
    An Esp Pediatr; 1998 Jan; 48(1):98-9. PubMed ID: 9542236
    [No Abstract]   [Full Text] [Related]  

  • 19. [Observation on the epidemiologic efficacy for 9 years on epidemic meningococcal polysaccharide vaccine of group A by district immunization method].
    Ma Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 1991 Apr; 12(2):69-71. PubMed ID: 2065343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effectiveness and duration of the immunity of the vaccine against serogroup A+C meningococcus].
    García Comas L; Ramírez Fernández R; Castañeda López R; Sanz Moreno JC; Vázquez Moreno J; Lasheras Carbajo MD; Barranco Ordoñez D; Ruiz Contreras J; Jover Ibarra J
    Rev Esp Salud Publica; 2000; 74(4):425-31. PubMed ID: 11031853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.